Department of Medicine, University of California, Irvine, Irvine, CA, United States.
Department of Public Health, University of California, Los Angeles, Los Angeles, CA, United States.
JMIR Res Protoc. 2024 Apr 22;13:e50032. doi: 10.2196/50032.
Asian Americans with metastatic cancer are an understudied population. The Describing Asian American Well-Being and Needs in Cancer (DAWN) Study was designed to understand the supportive care needs of Chinese-, Vietnamese-, and Korean-descent (CVK) patients with metastatic cancer.
This study aims to present the DAWN Study protocol involving a primarily qualitative, convergent, mixed methods study from multiple perspectives (patients or survivors, caregivers, and health care professionals).
CVK Americans diagnosed with solid-tumor metastatic cancer and their caregivers were recruited nationwide through various means (registries, community outreach newsletters, newspapers, radio advertisements, etc). Potentially eligible individuals were screened and consented on the web or through a phone interview. The study survey and interview for patients or survivors and caregivers were provided in English, traditional/simplified Chinese and Cantonese/Mandarin, Vietnamese, and Korean, and examined factors related to facing metastatic cancer, including quality of life, cultural values, coping, and cancer-related symptoms. Community-based organizations assisted in recruiting participants, developing and translating study materials, and connecting the team to individuals for conducting interviews in Asian languages. Health care professionals who have experience working with CVK patients or survivors with metastatic solid cancer were recruited through referrals from the DAWN Study community advisory board and were interviewed to understand unmet supportive care needs.
Recruitment began in November 2020; data collection was completed in October 2022. A total of 66 patients or survivors, 13 caregivers, and 15 health care professionals completed all portions of the study. We completed data management in December 2023 and will submit results for patients or survivors and caregivers to publication outlets in 2024.
Future findings related to this protocol will describe and understand the supportive care needs of CVK patients or survivors with metastatic cancer and will help develop culturally appropriate psychosocial interventions that target known predictors of unmet supportive care needs in Chinese, Vietnamese, and Korean Americans with metastatic cancer.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/50032.
亚洲裔美国转移性癌症患者是一个研究不足的群体。《描述亚裔美国人癌症中的健康和需求(DAWN)研究》旨在了解中国裔、越南裔和韩国裔(CVK)转移性癌症患者的支持性护理需求。
本研究旨在介绍 DAWN 研究方案,该方案涉及从多个角度(患者或幸存者、护理人员和医疗保健专业人员)进行的主要定性、收敛性、混合方法研究。
通过各种方式(登记处、社区外展通讯、报纸、广播广告等)在全国范围内招募被诊断患有实体瘤转移性癌症的 CVK 美国人和他们的护理人员。有潜力的合格人员通过网络或电话访谈进行筛选和同意。患者或幸存者和护理人员的研究调查和访谈以英语、繁体/简体中文和粤语/普通话、越南语和韩语提供,并检查了与面对转移性癌症相关的因素,包括生活质量、文化价值观、应对方式和癌症相关症状。社区组织协助招募参与者、开发和翻译研究材料,并将团队与以亚洲语言进行访谈的个人联系起来。具有与 CVK 转移性实体癌症患者或幸存者合作经验的医疗保健专业人员通过 DAWN 研究社区咨询委员会的推荐招募,并接受采访以了解未满足的支持性护理需求。
招募工作于 2020 年 11 月开始;数据收集于 2022 年 10 月完成。共有 66 名患者或幸存者、13 名护理人员和 15 名医疗保健专业人员完成了研究的所有部分。我们于 2023 年 12 月完成数据管理,并将于 2024 年向患者或幸存者和护理人员的出版物提交结果。
本协议的未来研究结果将描述和了解 CVK 转移性癌症患者或幸存者的支持性护理需求,并帮助开发针对中国裔、越南裔和韩国裔转移性癌症患者未满足的支持性护理需求的已知预测因素的文化上适当的社会心理干预措施。
国际注册报告标识符(IRRID):DERR1-10.2196/50032。